SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-24-037906
Filing Date
2024-03-22
Accepted
2024-03-22 16:31:56
Documents
14
Period of Report
2024-03-21
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm249589d1_8k.htm   iXBRL 8-K 24878
2 EXHIBIT 10.1 tm249589d1_ex10-1.htm EX-10.1 21305
  Complete submission text file 0001104659-24-037906.txt   226896

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA ptpi-20240321.xsd EX-101.SCH 3027
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE ptpi-20240321_lab.xml EX-101.LAB 34240
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ptpi-20240321_pre.xml EX-101.PRE 22367
17 EXTRACTED XBRL INSTANCE DOCUMENT tm249589d1_8k_htm.xml XML 3740
Mailing Address 1185 AVENUE OF THE AMERICAS, 3RD FLOOR NEW YORK NY 10036
Business Address 1185 AVENUE OF THE AMERICAS, 3RD FLOOR NEW YORK NY 10036 973-242-0005
Petros Pharmaceuticals, Inc. (Filer) CIK: 0001815903 (see all company filings)

IRS No.: 851410058 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39752 | Film No.: 24775739
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)